Marriott International (MAR) Business News

Track Marriott International in real time with a live news feed covering Marriott International stock news, official press releases, company announcements, and an archive of historical Marriott International news. ...more

  • Calendar
    Get instant access
    Sign up for free
    Month
    Jan
    Feb
    Mar
    Apr
    May
    Jun
    Jul
    Aug
    Sep
    Oct
    Nov
    Dec
    Date
    Su
    Mo
    Tu
    We
    Th
    Fr
    Sa
    Selected Filter
    No selection
8:30 AM | Friday | Oct 9, 2026 PRNewsWire

Marriott International Announces Release Date For Third Quarter 2026 Earnings

News Thumbnail
8:30 AM | Friday | Oct 9, 2026 PRNewsWire

Marriott International Announces Release Date For Third Quarter 2026 Earnings

News Thumbnail
4:00 AM | Tuesday | Oct 6, 2026 PRNewsWire

The Rise of Place: Marriott International Reveals Asia Pacific's Future of Food

News Thumbnail
9:57 AM | Monday | Oct 5, 2026 Proactive Investors

Lisata subsidiary Marea treats first patient in MAR002 acromegaly trial

News Thumbnail
8:00 AM | Monday | Oct 5, 2026 GlobeNewsWire

Marea Therapeutics, a Subsidiary of Lisata Therapeutics, Announces First Patient Dosed in Phase 2 Clinical Trial of MAR002, a Potential Best-in-disease Investigational Therapy for the Treatment of Acromegaly

News Thumbnail
10:56 AM | Monday | Sep 28, 2026 Zacks Investment Research

Forget Inflation: Funflation Is Here and These ETFs Are Riding on It

News Thumbnail
8:00 AM | Thursday | Sep 24, 2026 GlobeNewsWire

Marea Therapeutics, a Subsidiary of Lisata Therapeutics, Announces Upcoming Late-Breaking Presentation of MAR001 Clinical Data at the American Heart Association Scientific Sessions 2026

News Thumbnail
3:54 AM | Thursday | Sep 10, 2026 Defense World

Allworth Financial LP Has $5.55 Million Stock Holdings in Marriott International, Inc. $MAR

News Thumbnail
11:57 AM | Wednesday | Sep 9, 2026 Seeking Alpha

Marriott International, Inc. (MAR) Presents at Bank of America Gaming and Lodging Conference 2026 Transcript

News Thumbnail
9:00 AM | Wednesday | Sep 9, 2026 PRNewsWire

The Ritz-Carlton Yacht Collection Introduces Its Summer 2028 Mediterranean & Northern Europe Season

News Thumbnail
5:16 AM | Monday | Sep 7, 2026 Defense World

California State Teachers Retirement System Has $42.45 Billion Position in Marriott International, Inc. $MAR

News Thumbnail
news photo
Loading...

BETHESDA, Md., Oct. 9, 2026 /PRNewswire/ -- Marriott International, Inc. (Nasdaq: MAR) will report third quarter 2026 earnings results on Monday, November 2, 2026, at approximately 7:00 a.m.

Read full article redirect
8:30 AM | Friday | Oct 9, 2026

Marriott International Announces Release Date For Third Quarter 2026 Earnings

PRNewsWire

BETHESDA, Md., Oct. 9, 2026 /PRNewswire/ -- Marriott International, Inc. (Nasdaq: MAR) will report third quarter 2026 earnings results on Monday, November 2, 2026, at approximately 7:00 a.m.

Read full article arrow
News Thumbnail
8:30 AM | Friday | Oct 9, 2026

Marriott International Announces Release Date For Third Quarter 2026 Earnings

PRNewsWire

BETHESDA, Md., Oct. 9, 2026 /PRNewswire/ -- Marriott International, Inc. (Nasdaq: MAR) will report third quarter 2026 earnings results on Monday, November 2, 2026, at approximately 7:00 a.m.

Read full article arrow
News Thumbnail
4:00 AM | Tuesday | Oct 6, 2026

The Rise of Place: Marriott International Reveals Asia Pacific's Future of Food

PRNewsWire

Local cuisine emerges as the region's strongest dining force, as traditional restaurant settings give way to fluid, social spaces. SINGAPORE, Oct. 6, 2026 /PRNewswire/ -- Marriott International has unveiled Future of Food 2027, its latest report exploring food and beverage trends across Asia Pacific excluding China.

Read full article arrow
News Thumbnail
9:57 AM | Monday | Oct 5, 2026

Lisata subsidiary Marea treats first patient in MAR002 acromegaly trial

Proactive Investors

Lisata Therapeutics Inc (NASDAQ:LSTA, FRA:8NE) subsidiary Marea Therapeutics has dosed the first patient in a Phase 2 clinical trial of MAR002, a first-in-class antibody therapy for acromegaly, the company said on Monday.  Marea, which is developing medicines for cardioendocrine diseases, is advancing MAR002 as a potential new option for the rare endocrine disorder.

Read full article arrow
News Thumbnail
8:00 AM | Monday | Oct 5, 2026

Marea Therapeutics, a Subsidiary of Lisata Therapeutics, Announces First Patient Dosed in Phase 2 Clinical Trial of MAR002, a Potential Best-in-disease Investigational Therapy for the Treatment of Acromegaly

GlobeNewsWire

Trial follows promising MAR002 Phase 1 clinical trial results that demonstrated deep and durable IGF-1 suppression with PK properties that may enable dosing as infrequently as once every two weeks, compared to the daily subcutaneous injections required by the current standard of care

Read full article arrow
News Thumbnail
10:56 AM | Monday | Sep 28, 2026

Forget Inflation: Funflation Is Here and These ETFs Are Riding on It

Zacks Investment Research

ETFs like AWAY are riding on "funflation" as consumers keep spending on hobbies, travel, music and leisure despite higher prices.

Read full article arrow
News Thumbnail
8:00 AM | Thursday | Sep 24, 2026

Marea Therapeutics, a Subsidiary of Lisata Therapeutics, Announces Upcoming Late-Breaking Presentation of MAR001 Clinical Data at the American Heart Association Scientific Sessions 2026

GlobeNewsWire

SOUTH SAN FRANCISCO and LIBERTY CORNER, N.J., Sept. 24, 2026 (GLOBE NEWSWIRE) -- Marea Therapeutics, Inc. (“Marea”), a subsidiary of Lisata Therapeutics, Inc.
(Nasdaq: LSTA) (“Lisata”), a clinical-stage biotechnology company harnessing the latest advances in human genetics to develop first-in-class, next-generation medicines for cardioendocrine diseases, today announced that data from the Phase 2b TYDAL study of MAR001, a potential first-in-class monoclonal antibody targeting angiopoietin-like protein 4 (ANGPTL4), will be presented in a late-breaking science session at the American Heart Association (AHA) Scientific Sessions 2026, taking place November 6-9, 2026, in Chicago, Illinois.

Read full article arrow
News Thumbnail
3:54 AM | Thursday | Sep 10, 2026

Allworth Financial LP Has $5.55 Million Stock Holdings in Marriott International, Inc. $MAR

Defense World

Allworth Financial LP trimmed its holdings in Marriott International, Inc. (NASDAQ: MAR) by 39.6% in the undefined quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 14,976 shares of the company's stock after selling 9,812 shares during the period. Allworth Financial LP's holdings in Marriott

Read full article arrow
News Thumbnail
11:57 AM | Wednesday | Sep 9, 2026

Marriott International, Inc. (MAR) Presents at Bank of America Gaming and Lodging Conference 2026 Transcript

Seeking Alpha

Marriott International, Inc. (MAR) Presents at Bank of America Gaming and Lodging Conference 2026 Transcript

Read full article arrow
News Thumbnail
9:00 AM | Wednesday | Sep 9, 2026

The Ritz-Carlton Yacht Collection Introduces Its Summer 2028 Mediterranean & Northern Europe Season

PRNewsWire

Thoughtfully designed voyages across Europe balance iconic destinations with quieter coastal communities, creating space for unexpected moments of discovery along the way. FORT LAUDERDALE, Fla.

Read full article arrow
News Thumbnail
5:16 AM | Monday | Sep 7, 2026

California State Teachers Retirement System Has $42.45 Billion Position in Marriott International, Inc. $MAR

Defense World

California State Teachers Retirement System lifted its position in Marriott International, Inc. (NASDAQ: MAR) by 43,255.9% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 114,540,104 shares of the company's stock after acquiring an additional 114,275,918 shares during the period. California

Read full article arrow
News Thumbnail